Investment
Features
FeesSafety
Academy
More
Pluang+

Novo Resources files technical report confirming Belltopper Gold Project resource estimate in Victoria.

Company Fundamentals
22 Jul 2026
GlobeNewsWire
View Source
Neutral
pluang ai news

Novo Resources Corp. has filed a technical report on the Mineral Resource Estimate for the Leven Star Reef at its 100% owned Belltopper Gold Project in Victoria, Australia. The report, prepared by qualified experts, confirms the previously announced resource estimate with no material changes. This filing meets Canadian and ASX regulatory requirements and is available on SEDAR+ and Novo's website. The report supports Novo's ongoing exploration and development efforts in the region, highlighting the company's focus on gold projects with significant potential.

More News (NVO)

Eli Lilly to seek FDA approval for retatrutide after trials show average 56-pound weight loss

Eli Lilly to seek FDA approval for retatrutide after trials show average 56-pound weight loss

Eli Lilly announced plans to file for FDA approval of retatrutide, a new weight-loss drug, following phase 3 trials where participants lost an average of nearly 56 pounds over 80 weeks. The drug targets multiple hormones affecting appetite and metabo...

Market News
Bullish
1 day ago
Novo Resources confirms Leven Star gold resource and finds significant silver-antimony-zinc system at Wyloo.

Novo Resources confirms Leven Star gold resource and finds significant silver-antimony-zinc system at Wyloo.

Novo Resources has filed a technical report confirming the mineral resource estimate for the Leven Star Reef gold project in Victoria, Australia, matching earlier estimates. Additionally, drilling at the Wyloo Polymetallic Project in Western Australi...

Market News
Bullish
1 day ago
Novo Resources updates corporate presentation highlighting gold project progress and growth strategy.

Novo Resources updates corporate presentation highlighting gold project progress and growth strategy.

Novo Resources Corp. has released an updated corporate presentation detailing its strategic priorities, recent exploration results, and project advancements. The presentation provides investors with insights into the company's growth strategy and its...

Company Fundamentals
Bullish
1 day ago
US to impose phased tariffs on imported generic drugs starting August 2026 to boost local production

US to impose phased tariffs on imported generic drugs starting August 2026 to boost local production

The US announced a phased tariff plan on imported generic drugs starting August 1, 2026, with zero tariffs for two years, followed by a 100% tariff in August 2028 and 200% in 2029. This move aims to encourage generic drugmakers to relocate production...

Market News
Bearish
2 days ago
Novo Nordisk sues Eli Lilly over misleading GLP-1 drug ads claiming superior weight-loss results.

Novo Nordisk sues Eli Lilly over misleading GLP-1 drug ads claiming superior weight-loss results.

Novo Nordisk has filed a federal lawsuit against Eli Lilly, accusing the company of misleading advertising for its GLP-1 drugs Zepbound and Mounjaro. Novo claims Lilly's ads use outdated data and unfairly compare Lilly's highest drug doses to lower d...

Market News
Bearish
3 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App